Purple Biotech Reaches Recommended Phase 2 Dose for NT219

Go back to Purple Biotech Reaches Recommended Phase 2 Dose for NT219
(NASDAQ: PPBT) Delayed: 1.77 +0.07 (4.12%)
Previous Close $1.70    52 Week High
Open $1.80    52 Week Low
Day High $1.80    P/E N/A 
Day Low $1.70    EPS
Volume 39,512       

(NASDAQ: PPBT) Delayed: 1.77 +0.07 (4.12%)
Previous Close $1.70    52 Week High
Open $1.80    52 Week Low
Day High $1.80    P/E N/A 
Day Low $1.70    EPS
Volume 39,512